Pharmaceuticals

LLY news and market impact

Real-time Eli Lilly and Company news affecting stock and options prices

Latest LLY news

LOWFinancial Times — US3 days ago

Eli Lilly is signing a $2 billion deal with a Hong Kong biotech company for AI-powered drug development.

Eli Lilly is signing a $2 billion deal with a Hong Kong biotech company for AI-powered drug development. This represents a major investment in artificial intelligence applications for pharmaceutical research and development.

View all LLY events

How news affects LLY

Eli Lilly and Company (LLY) is sensitive to: drug approvals, obesity drug demand, earnings, Medicare policy.Major pharma — GLP-1 weight loss drugs (Mounjaro/Zepbound), insulin.

Related tickers

PFEPfizer Inc.JNJJohnson & JohnsonUNHUnitedHealth GroupXLVHealth Care Select Sector SPDR

Get LLY alerts before the market moves

AI-powered news filtering. Only what matters to your positions.

Start free trial

Frequently asked questions

What is moving LLY today?

Eli Lilly is signing a $2 billion deal with a Hong Kong biotech company for AI-powered drug development.

How do I get LLY news alerts?

Sign up for Tradar and add LLY to your watchlist. You'll get push notifications for high-impact news within seconds.